| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.9M | +4.0% | -9.1% |
| Cost of Revenue | $24.8M | +4.5% | -12.8% |
| Gross Profit | $8.1M | +2.2% | +4.5% |
| R&D Expense | $1.8M | +6.2% | -41.8% |
| SG&A Expense | $3.7M | -14.6% | -25.8% |
| Operating Income | -$1.8M | +17.8% | +70.0% |
| Pre-tax Income | -$5.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.9M | -17.6% | -77.3% |
| Accounts Receivable | $23.2M | +16.6% | -12.4% |
| Current Assets | $29.6M | +10.0% | -36.1% |
| Total Assets | $42.8M | +6.5% | -28.6% |
| Current Liabilities | $88.0M | +200.1% | +6.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.6M | — | — |
| Investing Cash Flow | -$4.0M | — | — |
| Financing Cash Flow | -$633K | — | — |
| +7.6% |
| +51.2% |
| Income Tax | $25K | +316.7% | — |
| Net Income | -$5.2M | +7.7% | +51.2% |
| EPS (Basic) | -$3.63 | +19.3% | -359.5% |
| EPS (Diluted) | -$3.63 | +19.3% | -359.5% |
| $39.9M |
| -5.6% |
| — |
| Total Liabilities | $88.0M | +8.0% | +5.5% |
| Stockholders' Equity | -$45.2M | -9.4% | -92.3% |